Keywords: Breast, CancerThis study aimed to investigate the longitudinal changes in functional tumor volume (FTV) and background parenchymal enhancement (BPE) derived from dynamic contrast-enhanced breast MRI during neoadjuvant endocrine therapy (NET). For comparison, we also evaluated a similar cohort of patients who received standard neoadjuvant chemotherapy (NAC). Similar to the NAC cohort, the NET cohort showed early changes in FTV and BPE as early as three weeks of treatment. In the NET cohort, early BPE decrease was prominent especially for patients with higher baseline BPE and premenopausal patients. These finding illustrate the potential of MRI metrics as early imaging biomarkers for NET.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords